drugset / Trial / NCT00624273

Sildenafil for Treatment of Digital Ulcers in Patients With Systemic Sclerosis

NCT00624273

Phase 2 Completed 17 enrolled Charite University, Berlin, Germany
NaSingle-groupOpen-labelTreatment

Summary

This is a pilot study analyzing the effect of sildenafil therapy on digital ulcers in systemic sclerosis. We want to analyze ulcer healing by measuring the size of digital ulcers and their count and analyze the effect of sildenafil on angiography.

Timeline

Start
2004-02
Primary completion
2004-11
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 25 mg Oral

Indications